Skip to main content

Table 3 Predictors of Chikungunya rheumatism issues in subjects ≥ 15 years (final model), TELECHIK study, La Réunion, 2007-2008

From: Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study

Outcomes (versus recovery as reference) Relapsing rheumatic musculoskeletal pain Lingering rheumatic musculoskeletal pain
Determinants Adjusted OR 95% CI P-value Adjusted OR 95% CI P-value
Gender       
Male 1    1   
Female 0.92 0.44, 1.92 0.831 1.03 0.45, 2.31 0.951
Age       
15 to 29 yrs 1    1   
30 to 44 yrs 2.08 0.81, 5.32 0.124 2.29 0.74, 6.99 0.146
45 to 59 yrs 2.93 1.00, 8.57 0.049 6.35 1.82, 22.10 0.004
≥ 60 yrs 10.44 3.50, 31.10 < 0.001 22.30 6.36, 78.06 < 0.001
Initial rheumatic involvement       
Low to moderate 1    1   
Severe 3.60 1.58, 8.21 0.002 5.52 2.20, 13.81 < 0.001
CHIKV-specific IgG titre (per one unit increase) 3.16 1.82, 5.48 < 0.001 6.16 2.88, 13.20 < 0.001
  1. OR, odds ratio; CHIKV, Chikungunya virus. All estimations and P-values are weighted by the sampling scheme. All subjects had joint or muscle pain at disease onset. Joint or muscle pain with at most two of the three following conditions: fever, six or more localisations of arthralgias, or at least four other symptoms; fever and six or more localizations of arthralgias and at least four other symptoms.